Upcoming AMGN earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
November 2, 2026after market close
Amgen is scheduled to report earnings on this date according to earnings-calendar data from Finnhub and Financial Modeling Prep. Dates can change until the company officially confirms them.
Amgen's Q2 FY2026 revenue grew 10% to $10.1B and net income surged 66% to $2.4B, driven by volume and lower amortization, while biosimilar and IRA headwinds…
Amgen delivered a strong Q1 2026 with revenue up 5.8% YoY to $8.62B, while operating income more than doubled (+126.3%) to $2.67B driven by lower cost of…
Amgen delivered a strong FY2025 with revenue rising 10.0% to $36.8B and net income nearly doubling (+88.5%) to $7.7B, driven by improved cost efficiency and…
Amgen (AMGN) is scheduled to report earnings on November 2, 2026, after market close, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
Amgen's most recent earnings report was its Q2 FY2026 10-Q, filed with the SEC on August 5, 2026.
EarningsLens publishes free AI analysis of every AMGN 10-K and 10-Q filing. The latest covers Q2 FY2026 — open it from the report history on this page.
Like all U.S.-listed public companies, Amgen reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.